ArticleCancer prevention research (Philadelphia, Pa.)2022

Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy.

Meghna S Trivedi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.